3D cell culture firm Reinnervate announces the release of Alvetex®Scaffold 96 well plates for high throughput 3D cell-based assays
14 December 2012
Sedgefield, UK. November 2012 – Market leading 3D cell culture company, Reinnervate Ltd, today announced that it has launched and commenced shipments of Alvetex® Scaffold 96 well plates to customers. “We are very pleased that the pent up de...
Medicyte GmbH and Reinnervate Ltd to collaborate on development of next generation predictive 3D cell toxicity assays
09 July 2012
Heidelberg, Germany and Sedgefield, UK. 9th July 2012 – Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte(inventors of the upcyte® technology) and ...
Top award for 3D cell culture pioneer, Stefan Przyborski, of Reinnervate Ltd
27 June 2012
Sedgefield, UK. June 2012 – Prof Stefan Przyborski, CSO and founder of Reinnervate Ltd has been recognised with a top award from the Royal Society of Chemistry. The Rita and John Cornforth award 2012 recognises Prof. Przyborski’s leadership...
Reinnervate and Tecan to develop automated 3D cell culture solutions for improved cellular assays
17 June 2012
Sedgefield, UK and Männedorf, Switzerland. 7 June 2012. Reinnervate Ltd and Tecan Trading AG, have signed a co-marketing agreement to develop a range of automated solutions for 3D cell culture, based on the Freedom EVO® liquid handling work...
Reinnervate Ltd and Roslin Cellab announce plans to collaborate
30 April 2012
Sedgefield, UK. April 2012. Reinnervate Ltd and Roslin Cellab, two leading UK companies in the fields of 3D cell culture and stem cell biology, today announced that they will join forces to develop protocols for the three dimensional growth...
Reinnervate Ltd announce Kirkstall Ltd collaboration
30 March 2012
Reinnervate (inventors of Alvetex® Scaffold) and Kirkstall (developers of the Quasi-Vivo® system) today announced that they will collaborate to bring next-generation three dimensional (3D) cell culture products to market in 2012. The two UK...
Reinnervate and Mirus Bio announce collaboration with the launch of the new 3D Transfection System for the transfection of cells cultured in Alvetex®
16 November 2011
Sedgefield, UK. November 2011. Reinnervate (Sedgefield, UK) and Mirus Bio (Madison, USA) today announced a commercial agreement to launch a new range of products for the transfection of cells cultured in 3D. Under the agreement, Mirus will ...
Alvetex® voted one of most technologically significant new research products by R&D magazine
27 June 2011
Sedgefield, UK. 23rd June 2011. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is delighted to announce that Alvetex®, its breakthrough 3D cell culture technology, is among the winners of t...
Alvetex® named in the top ten life science innovations of 2010 by The Scientist magazine
06 December 2010
Sedgefield, UK. 1st December 2010. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is proud to announce that Alvetex®, its breakthrough 3D cell culture technology, is among the winners of Th...
Reinnervate launches Alvetex®, a breakthrough product for enabling routine 3D cell culture
22 November 2010
Sedgefield, UK. 22nd November 2010. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is very pleased to announce today the first commercial launch of Alvetex®, its breakthrough 3D cell cultur...